BioMimetic Therapeutics Inc. (BMTI) is in the Health Care Industry

• Sort by
• View Related Content by Tag

• BioMimetic Therapeutics, Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Operator instructions Our first question comes from Tao Levy with Deutsche Bank. Please proceed sir. Imron Zafar – Deutsche Bank Good afternoon. This is actually Imron in for Tao. Thanks for taking my questions. My first question is on the Canadian filing. Can...

  Earnings calls 2008-09-03

  Tags: BioMimetic Therapeutics Inc.

• BioMimetic Therapeutics Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Thank you. Operator Instructions Your next question comes from the line of Tao Levy with Deutsche Bank. Please proceed. Tao Levy - Deutsche Bank Good morning. Tao from Deutsche. Can you hear me? Sam Lynch Yes. Tao Levy - Deutsche Bank Hey. How you guys doing? Sam...

  Earnings calls 2008-05-30

  Tags: BioMimetic Therapeutics Inc.

• BioMimetic Therapeutics Inc. Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Thank you. Operator Instructions Your first question comes from Tao Levy from Deutsche Bank, please proceed. Tao Levy -- Deutsche Bank Just a couple of quick questions, obviously we just saw you guys last Thursday at the analyst meeting, but maybe Sam, could you tell...

  Earnings calls 2008-04-17

  Tags: BioMimetic Therapeutics Inc.

• BioMimetic Therapeutics, Inc Q3 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Thank you. Ladies and gentlemen, if you wish to ask a question please press "*" followed by "1" on your touch-tone telephone. If your question has been answered, or you wish to withdraw your question press "*" followed by "2". Questions will be taken...

  Earnings calls 2007-11-14

  Tags: BioMimetic Therapeutics Inc.

Additional Resources

• BioMimetic Therapeutics Announces No Changes Requested by Independent Data Monitoring Committee to Pivotal Trial Design for Augment™ Bone Graft

  268 of 396 Patients Enrolled to Date in U.S. Pivotal Trial FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today results from the independent Data Monitoring Committee DMC that is overseeing the Company's ongoing U.S. pivotal trial evaluating Augment Bone Graft for the treatment of foot and...

  Articles 2008-09-23

• BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the UBS Global Life Sciences Conference

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, CEO and president, will provide an update of corporate activities at the 2008 UBS Global Life Sciences Conference on Thursday, September 25 at 9:30 a.m. EDT. The presentation will take place in Carnegie Hall Ballroom...

  Articles 2008-09-22

• BioMimetic Therapeutics to Report 2008 Second Quarter Financial Results on August 11

  Company to Release Results of Augment Injectable Bone Graft in Foot and Ankle Fusions FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Company plans to release its financial results for the three months ended June 30, 2008, on Monday, August 11, 2008 after the...

  Articles 2008-08-06

• BioMimetic Therapeutics Launches Augment™ as the New Brand Name for the Company's Orthopedic Product Line

  - Clinical Investigator to Present Canadian Trial Results at AOFAS Meeting - FRANKLIN, Tenn. -- BioMimetic Therapeutics (NASDAQ: BMTI) today introduced Augment[TM] as the new brand name for its portfolio of orthobiologic product candidates. This name replaces the GEM (Growth-factor Enhanced Matrix) family of trademarks,...

  Articles 2008-06-24

• BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Jefferies 2nd Annual Healthcare Conference

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Larry Bullock, CFO, will provide an update of corporate activities at the Jefferies 2nd Annual Healthcare Conference. The presentation will take place in New York City on Wednesday, June 25 at 2:00 p.m. EDT. ...

  Articles 2008-06-20

• BioMimetic Therapeutics Announces Highlights from Annual Meeting of Stockholders

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced the results of its 2008 Annual Meeting of Stockholders that took place on June 12, 2008 at the Company's headquarters. The Company's shareholders voted in favor of all proposals identified in the Proxy Statement. Re-elected...

  Articles 2008-06-12

• BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Bank of America Securities 2008 Healthcare Conference

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Larry Bullock, CFO, will provide an update of corporate activities at the Bank of America Securities 2008 Healthcare Conference. The presentation will take place in Ballroom 2 of the Four Seasons Hotel in Las Vegas on Tuesday, May 13...

  Articles 2008-05-09

• BioMimetic Therapeutics Reports 2008 First Quarter Results

  $33.4 Million Cash Received from the Sale of Orofacial Therapeutic Business FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results as of and for the three months ended March 31, 2008. For the three months ended March 31, 2008, the Company reported net income...

  Articles 2008-05-08

• BioMimetic Therapeutics to Report 2008 First Quarter Financial Results on May 8

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Company plans to release its financial results for the three months ended March 31, 2008 on Thursday, May 8, 2008 after the close of the market, and will host a conference call and audio webcast at 8:30 EDT...

  Articles 2008-05-07

• BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Deutsche Bank 33rd Annual Health Care Conference

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, CEO and president, will provide an update of corporate activities at the Deutsche Bank 33rd Annual Health Care Conference. The presentation will take place in the Hutchinson Ballroom at the Intercontinental Hotel in Boston on...

  Articles 2008-05-01

• BioMimetic Therapeutics Receives Written Communication from FDA Confirming Status of Ongoing Pivotal Trial for GEM OS1

  No Changes Recommended to Trial Design Company to Host Conference Call Tuesday, April 22 FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Food & Drug Administration FDA issued a letter to the Company confirming that its U.S. GEM OS1 pivotal study for...

  Articles 2008-04-21

• BellwetherReport.com Free Analyst Review for TSRA, APOL, BMTI, and OPLK

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased research on the companiesmentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have scheduled interviews with a number of the...

  Articles 2008-03-28

• BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review

  FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today addressed a communication the U.S. Food and Drug Administration ("FDA") released on its website this afternoon regarding the agency's ongoing safety review of Regranex[R], a Johnson & Johnson product. Regranex is composed of recombinant human Platelet-Derived Growth Factor (rhPDGF-BB) becaplermin in...

  Articles 2008-03-28

• CHAT LIVE in the only dedicated CHAT ROOM for (Nasdaq: BMTI)shareholders!

  M2 PRESSWIRE-28 March 2008-Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for (Nasdaq: BMTI)shareholders!C1994-2008 M2 COMMUNICATIONS LTD RDATE:28032008 AUSTIN, TX -- STOCKWIRE.com, one of the largest investment websites on the internet, is proud to announce the official launch...

  Articles 2008-03-28

• Small Cap Stocks to Watch - BMTI, CYCL, BEST, CPYE.

  M2 PRESSWIRE-28 March 2008-SmallCapReview.com: Small Cap Stocks to Watch - BMTI, CYCL, BEST, CPYEC1994-2008 M2 COMMUNICATIONS LTD RDATE:28032008 To register for the Free SmallCapReview Newsletter and automatically be entered to win a Blackberry Pearl visit http://www.smallcapreview.com/subscribe.htmBioMimetic Therapeutics (Nasdaq:...

  Articles 2008-03-28

• BioMimetic Therapeutics Reports 2007 Fourth Quarter and Year-end Results

  Year Marked by Strong Cash Position, Positive Orthopedic Data and Progressing Clinical Trials FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results as of and for the three and twelve months ended December 31, 2007. For the three months ended December 31, 2007, the...

  Articles 2008-03-12